![](/img/cover-not-exists.png)
Twelve-Month, Randomized, Controlled Trial of Bimatoprost 0.01%, 0.0125%, and 0.03% in Patients with Glaucoma or Ocular Hypertension
L. Jay Katz, John S. Cohen, Amy L. Batoosingh, Carlos Felix, Vincent Shu, Rhett M. SchiffmanVolume:
149
Year:
2010
Language:
english
Pages:
6711
DOI:
10.1016/j.ajo.2009.12.003
File:
PDF, 1012 KB
english, 2010